144 related articles for article (PubMed ID: 984786)
1. Comparative pharmacology of josamycin and erythromycin stearate.
Strausbaugh LJ; Bolton WK; Dilworth JA; Guerrant RL; Sande MA
Antimicrob Agents Chemother; 1976 Sep; 10(3):450-6. PubMed ID: 984786
[TBL] [Abstract][Full Text] [Related]
2. [The pharmacokinetics of josamycin].
Wildfeuer A; Lemme JD
Arzneimittelforschung; 1985; 35(3):639-43. PubMed ID: 4039591
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction.
Sefton AM; Maskell JP; Kerawala C; Cannell H; Seymour A; Sun ZM; Williams JD
J Antimicrob Chemother; 1990 Jun; 25(6):975-84. PubMed ID: 2196261
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of macrolide action: the josamycin and erythromycin cases.
Lovmar M; Tenson T; Ehrenberg M
J Biol Chem; 2004 Dec; 279(51):53506-15. PubMed ID: 15385552
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs.
Qin XY; Pilot MA; Thompson HH; Maskell JP
J Antimicrob Chemother; 1986 Dec; 18(6):747-56. PubMed ID: 3818498
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus.
Wilson SZ; Martin RR; Putman M
Antimicrob Agents Chemother; 1977 Mar; 11(3):407-10. PubMed ID: 324389
[TBL] [Abstract][Full Text] [Related]
8. Plasma and saliva concentrations for a new formulation of erythromycin stearate.
Berend N; Rutland J; Marlin GE
Curr Med Res Opin; 1979; 6(2):118-23. PubMed ID: 467089
[TBL] [Abstract][Full Text] [Related]
9. Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.
Wenzel RP; Hendley JO; Dodd WK; Gwaltney JM
Antimicrob Agents Chemother; 1976 Dec; 10(6):899-901. PubMed ID: 795375
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows.
Baggot JD; Gingerich DA
Res Vet Sci; 1976 Nov; 21(3):318-23. PubMed ID: 1030820
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
Shanson DC; Tidbury P; McNabb WR; Tadayon M
J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.
Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L; Josefsson K
Pharmacology; 1984; 29(6):305-11. PubMed ID: 6334320
[TBL] [Abstract][Full Text] [Related]
13. A comparison of josamycin with macrolides and related antibiotics on isolated rat atria.
Tamargo J; De Miguel B; Tejerina MT
Eur J Pharmacol; 1982 Jun; 80(4):285-93. PubMed ID: 7106186
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses.
Okolicsanyi L; Venuti M; Strazzabosco M; Biral A; Orlando R; Iemmolo RM; Nassuato G; Muraca M; Padrini G; Miglioli PA
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):434-8. PubMed ID: 4044077
[TBL] [Abstract][Full Text] [Related]
15. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
[TBL] [Abstract][Full Text] [Related]
16. Antibiotics excretion in canine vaginal and urethral secretions.
Hoyme U; Baumueller A; Madsen PO
Invest Urol; 1978 Jul; 16(1):35-8. PubMed ID: 29017
[TBL] [Abstract][Full Text] [Related]
17. Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatis.
Robson HG; Shah PP; Lalonde RG; Hayes L; Senikas VM
Sex Transm Dis; 1983; 10(3):130-4. PubMed ID: 6648747
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability.
McCracken GH; Ginsburg CM; Clahsen JC; Thomas ML
Pediatrics; 1978 Nov; 62(5):738-43. PubMed ID: 581516
[TBL] [Abstract][Full Text] [Related]
20. Macrolide accumulation by Bacteroides fragilis ATCC 25285.
Muto Y; Bandoh K; Watanabe K; Katoh N; Ueno K
Antimicrob Agents Chemother; 1989 Feb; 33(2):242-4. PubMed ID: 2719467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
